272 related articles for article (PubMed ID: 27429984)
21. Epstein-Barr virus in autoimmune diseases.
Toussirot E; Roudier J
Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):883-96. PubMed ID: 19028369
[TBL] [Abstract][Full Text] [Related]
22. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
Tzioufas AG; Voulgarelis M
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
[TBL] [Abstract][Full Text] [Related]
23. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
24. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases.
Stojanovich L; Milovanovich B; de Luka SR; Popovich-Kuzmanovich D; Bisenich V; Djukanovich B; Randjelovich T; Krotin M
Lupus; 2007; 16(3):181-5. PubMed ID: 17432103
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
27. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
[TBL] [Abstract][Full Text] [Related]
28. [Gougerot-Sjögren syndrome. Risk of lymphoma].
Mariette X
Presse Med; 1999 Jun; 28(22):1214-8. PubMed ID: 10414252
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma.
Hollander P; Rostgaard K; Smedby KE; Chang ET; Amini RM; de Nully Brown P; Glimelius B; Adami HO; Melbye M; Glimelius I; Hjalgrim H
Am J Epidemiol; 2015 Oct; 182(7):624-32. PubMed ID: 26346543
[TBL] [Abstract][Full Text] [Related]
30. Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type.
Thieblemont C; Bertoni F; Copie-Bergman C; Ferreri AJ; Ponzoni M
Semin Cancer Biol; 2014 Feb; 24():33-42. PubMed ID: 24333758
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.
Dias C; Isenberg DA
Nat Rev Rheumatol; 2011 Jun; 7(6):360-8. PubMed ID: 21637317
[TBL] [Abstract][Full Text] [Related]
32. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
Al-Awadhi AM; Olusi S; Hasan EA; Abdullah A
Singapore Med J; 2007 Sep; 48(9):847-9. PubMed ID: 17728967
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of serum myeloperoxidase in patients with active rheumatoid arthritis.
Wang W; Jian Z; Guo J; Ning X
Life Sci; 2014 Nov; 117(1):19-23. PubMed ID: 25261597
[TBL] [Abstract][Full Text] [Related]
34. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).
Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM;
J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460
[TBL] [Abstract][Full Text] [Related]
35. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
[TBL] [Abstract][Full Text] [Related]
36. [Malignancy in autoimmune diseases].
Sugai S
Nihon Rinsho Meneki Gakkai Kaishi; 1996 Feb; 19(1):1-14. PubMed ID: 8681020
[TBL] [Abstract][Full Text] [Related]
37. Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE.
Rossi E; Catania G; Truini M; Ravetti GL; Grassia L; Marmont AM
Clin Exp Rheumatol; 2011; 29(3):555-9. PubMed ID: 21722503
[TBL] [Abstract][Full Text] [Related]
38. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
Mackay F; Sierro F; Grey ST; Gordon TP
Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
[TBL] [Abstract][Full Text] [Related]
39. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
40. Predicting progression to lymphoma in Sjögren's syndrome patients.
Giannouli S; Voulgarelis M
Expert Rev Clin Immunol; 2014 Apr; 10(4):501-12. PubMed ID: 24451006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
